文献速递卫生政策与健康促进妇幼与学校卫生

跨性别人群亲密伴侣暴力:患病率与相关因素的系统综述与荟萃分析

Intimate Partner Violence in Transgender Populations: Systematic Review and Meta-analysis of Prevalence and Correlates.
PubMed 文献 · Am J Public Health · 2020-07-16

跨性别人群亲密伴侣暴力(IPV)终身物理IPV中位患病率为37.5%,终身性IPV为25.0%,过去一年物理IPV为16.7%,过去一年性IPV为10.8%。与顺性别个体相比,跨性别个体经历任何IPV的风险比为1.66(95%CI 1.36-2.03),物理IPV为2.19(95%CI 1.66-2.88),性IPV为2.46(95%CI 1.64-3.69)。

要点

  • 跨性别人群IPV患病率显著高于顺性别个体,任何IPV风险比为1.66。
  • 跨性别个体物理IPV风险比为2.19,性IPV风险比为2.46。
  • 出生指派性别或二元/非二元认同间IPV患病率无显著差异。

核心结论

  • 跨性别人群IPV受害患病率显著高于顺性别个体,且与出生指派性别无关。
  • 出生指派男性与指派女性的跨性别个体IPV患病率相近,二元与非二元认同者物理IPV患病率也无显著差异。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、CINAHL、灰色文献、期刊目录和会议摘要,纳入2019年7月前发表的定量文献。

主要发现

  • 跨性别人群终身物理IPV中位患病率为37.5%,终身性IPV为25.0%,过去一年物理IPV为16.7%,过去一年性IPV为10.8%。
  • 与顺性别个体相比,跨性别个体任何IPV风险比为1.66(95%CI 1.36-2.03),物理IPV为2.19(95%CI 1.66-2.88),性IPV为2.46(95%CI 1.64-3.69)。
  • 与顺性别女性相比,跨性别个体的IPV差异持续存在。
  • 出生指派女性与指派男性的跨性别个体在任何IPV、物理IPV或性IPV患病率上无显著差异。
  • 二元与非二元认同的跨性别个体在物理IPV患病率上无显著差异。

临床怎么用

  • 跨性别人群IPV患病率极高,应纳入初级保健IPV筛查的优先人群。
  • 需在政策、人际和个体层面开展干预以预防和应对IPV。
  • 临床应关注跨性别IPV受害者的性风险、物质使用和心理健康问题。

局限性

  • 需要更多研究以进一步确认出生指派性别和二元/非二元认同间IPV患病率的比较结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Transgender individuals experience unique vulnerabilities to intimate partner violence (IPV) and may experience a disproportionate IPV burden compared with cisgender (nontransgender) individuals.Objectives: To systematically review the quantitative literature on prevalence and correlates of IPV in transgender populations.Search Methods: Authors searched research databases (PubMed, CINAHL), gray literature (Google), journal tables of contents, and conference abstracts, and consulted experts in the field. Authors were contacted with data requests in cases in which transgender participants were enrolled in a study, but no disaggregated statistics were provided for this population.Selection Criteria: We included all quantitative literature published before July 2019 on prevalence and correlates of IPV victimization, perpetration, or service utilization in transgender populations. There were no restrictions by sample size, year, or location.Data Collection and Analysis: Two independent reviewers conducted screening. One reviewer conducted extraction by using a structured database, and a second reviewer checked for mistakes or omissions. We used random-effects meta-analyses to calculate relative risks (RRs) comparing the prevalence of IPV in transgender individuals and cisgender individuals in studies in which both transgender and cisgender individuals were enrolled. We also used meta-analysis to compare IPV prevalence in assigned-female-sex-at-birth and assigned-male-sex-at-birth transgender individuals and to compare physical IPV prevalence between nonbinary and binary transgender individuals in studies that enrolled both groups.Main Results: We identified 85 articles from 74 unique data sets (ntotal = 49 966 transgender participants). Across studies reporting it, the median lifetime prevalence of physical IPV was 37.5%, lifetime sexual IPV was 25.0%, past-year physical IPV was 16.7%, and past-year sexual IPV was 10.8% among transgender individuals. Compared with cisgender individuals, transgender individuals were 1.7 times more likely to experience any IPV (RR = 1.66; 95% confidence interval [CI] = 1.36, 2.03), 2.2 times more likely to experience physical IPV (RR = 2.19; 95% CI = 1.66, 2.88), and 2.5 times more likely to experience sexual IPV (RR = 2.46; 95% CI = 1.64, 3.69). Disparities persisted when comparing to cisgender women specifically. There was no significant difference in any IPV, physical IPV, or sexual IPV prevalence between assigned-female-sex-at-birth and assigned-male-sex-at-birth individuals, nor in physical IPV prevalence between binary- and nonbinary-identified transgender individuals. IPV victimization was associated with sexual risk, substance use, and mental health burden in transgender populations.Authors' Conclusions: Transgender individuals experience a dramatically higher prevalence of IPV victimization compared with cisgender individuals, regardless of sex assigned at birth. IPV prevalence estimates are comparably high for assigned-male-sex-at-birth and assigned-female-sex-at-birth transgender individuals, and for binary and nonbinary transgender individuals, though more research is needed.Public Health Implications: Evidence-based interventions are urgently needed to prevent and address IPV in this high-risk population with unique needs. Lack of legal protections against discrimination in employment, housing, and social services likely foster vulnerability to IPV. Transgender individuals should be explicitly included in US Preventive Services Task Force recommendations promoting IPV screening in primary care settings. Interventions at the policy level as well as the interpersonal and individual level are urgently needed to address epidemic levels of IPV in this marginalized, high-risk population.

来源:Am J Public Health,查看原文。版权归原作者所有。

引用

  1. Peitzmeier SM, Malik M, Kattari SK, et al. Intimate Partner Violence in Transgender Populations: Systematic Review and Meta-analysis of Prevalence and Correlates. Am J Public Health. 2020. PMID: 32673114. doi:10.2105/AJPH.2020.305774

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。